Lataa...
The ubiquitin–proteasome system as a molecular target in solid tumors: an update on bortezomib
The ubiquitin–proteasome system has become a promising molecular target in cancer therapy due to its critical role in cellular protein degradation, interaction with cell cycle and apoptosis regulation, and unique mechanism of action. Bortezomib (PS-341) is a potent and specific reversible proteasome...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2886336/ https://ncbi.nlm.nih.gov/pubmed/20616904 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|